EAU23

We are happy to say that #EchoLaser #SoracteLite #TPLA has been recognized as one of the most crucial updates for #EAU23. A safe way to treat #BPH that preserves sexual function....

The pogress at European Association of Urology (EAU)

EAU2023 has come to an end. Scientific sessions demonstrated the constant and solid progress EchoLaser is making as a game changer for the treatment of BPH: The first randomized clinical trial vs TURP shows that 96% of the patients treated with EchoLaser were able to...

EchoLaser SoracteLite TPLA: now on RAI national TV

TV coverage of EchoLaser for BPH (Benign Prostatic Hyperplasia) on RAI, Italian state television. Prof. Pierluigi Bove illustrates the benefits of this new and fast emerging technology. Prof. Bove was one of the first users of EchoLaser and is the principal...

SoracteLite in UK

Ideal Medical Solutions, exclusive distributor of Elesta #EchoLaser in UK/IRE, has launched a campaign to increase awareness on Benign Prostatic Hyperplasia, a disease which affects 1 out of 2 males above 50 years. Patients can scan a QR Code and book a free...